Company Filing History:
Years Active: 2007
Title: The Innovations of Daniel Trepanier
Introduction
Daniel Trepanier is an accomplished inventor based in Edmonton, Canada. He is known for his significant contributions to the field of pharmaceuticals, particularly through his innovative work on rapamycin carbohydrate derivatives. His research focuses on enhancing the pharmacokinetic and pharmacodynamic profiles of existing drugs.
Latest Patents
Trepanier holds a patent for his invention titled "Rapamycin carbohydrate derivatives." This invention provides modified rapamycins that have specific monosaccharide(s), oligosaccharide(s), pseudosugar(s), or derivatives thereof attached through a linker. The goal is to create rapamycin carbohydrate derivatives that exhibit enhanced pharmacokinetic and/or pharmacodynamic profiles. For instance, the administration of these derivatives results in altered pharmacokinetic profiles and reduced toxicities. This innovation offers compounds with characteristics that are distinct from other drugs in its class, such as rapamycin.
Career Highlights
Daniel Trepanier has made significant strides in his career, particularly through his work at Isotechnika Inc. His research has contributed to advancements in drug development and has the potential to improve therapeutic outcomes for patients.
Collaborations
Trepanier has collaborated with notable colleagues, including Mark D Abel and Roman Szweda. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Daniel Trepanier's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions through the development of rapamycin carbohydrate derivatives highlight the importance of research in creating safer and more effective medications.